Search Results

You are looking at 1 - 10 of 132 items for :

Clear All
Chanyang Kim Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Korea

Search for other papers by Chanyang Kim in
Google Scholar
PubMed
Close
and
Seungjoon Park Department of Pharmacology and Medical Research Center for Bioreaction to ROS and Biomedical Science Institute, School of Medicine, Kyung Hee University, Seoul, Korea

Search for other papers by Seungjoon Park in
Google Scholar
PubMed
Close

( 13 ). When IGF-1 binds to its corresponding receptor, it triggers downstream signaling pathways, of which the most important is the phosphatidylinositol-3-kinase (PI3K)/Akt pathway ( 14 ). The PI3K/Akt pathway has been implicated in the regulation of

Open access
Thomas Crezee Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Thomas Crezee in
Google Scholar
PubMed
Close
,
Mirela Petrulea Department of Endocrinology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

Search for other papers by Mirela Petrulea in
Google Scholar
PubMed
Close
,
Doina Piciu Department of Endocrinology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Doina Piciu in
Google Scholar
PubMed
Close
,
Martin Jaeger Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, The Netherlands
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania

Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Close
,
Jan W A Smit Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Jan W A Smit in
Google Scholar
PubMed
Close
,
Theo S Plantinga Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania

Search for other papers by Theo S Plantinga in
Google Scholar
PubMed
Close
,
Carmen E Georgescu Department of Endocrinology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Endocrinology Clinic, Cluj County Emergency Hospital, Cluj-Napoca, Romania

Search for other papers by Carmen E Georgescu in
Google Scholar
PubMed
Close
, and
Romana Netea-Maier Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, The Netherlands
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania

Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Close

disease is confronted with long-term disease and increased risk of death as no curative treatment options are available ( 5 , 6 , 7 ). The intracellular proteins PI3K, Akt and mTOR are part of a central signaling pathway in NMTC tumorigenesis by

Open access
Cleofas Marcial-Medina Departamento de Biologia Celular, Cinvestav-IPN, Mexico City, Mexico

Search for other papers by Cleofas Marcial-Medina in
Google Scholar
PubMed
Close
,
Alejandra Ordoñez-Moreno Departamento de Biologia Celular, Cinvestav-IPN, Mexico City, Mexico

Search for other papers by Alejandra Ordoñez-Moreno in
Google Scholar
PubMed
Close
,
Christian Gonzalez-Reyes Departamento de Biologia Celular, Cinvestav-IPN, Mexico City, Mexico

Search for other papers by Christian Gonzalez-Reyes in
Google Scholar
PubMed
Close
,
Pedro Cortes-Reynosa Departamento de Biologia Celular, Cinvestav-IPN, Mexico City, Mexico

Search for other papers by Pedro Cortes-Reynosa in
Google Scholar
PubMed
Close
, and
Eduardo Perez Salazar Departamento de Biologia Celular, Cinvestav-IPN, Mexico City, Mexico

Search for other papers by Eduardo Perez Salazar in
Google Scholar
PubMed
Close

, 15 , 16 ). Moreover, FFAR1 and FFAR4 are expressed in MDA-MB-231 and MCF-7 breast cancer cells and mammary non-tumorigenic epithelial cells MCF10A ( 9 , 11 , 17 ). The PI3K/AKT/mTOR pathway has been involved in growth, proliferation, survival

Open access
Weiwei Liang Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Search for other papers by Weiwei Liang in
Google Scholar
PubMed
Close
,
Yilin Zhang Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China

Search for other papers by Yilin Zhang in
Google Scholar
PubMed
Close
,
Yan Guo Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Search for other papers by Yan Guo in
Google Scholar
PubMed
Close
,
Pengyuan Zhang Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Search for other papers by Pengyuan Zhang in
Google Scholar
PubMed
Close
,
Jiewen Jin Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Search for other papers by Jiewen Jin in
Google Scholar
PubMed
Close
,
Hongyu Guan Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Search for other papers by Hongyu Guan in
Google Scholar
PubMed
Close
, and
Yanbing Li Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Search for other papers by Yanbing Li in
Google Scholar
PubMed
Close

Signaling Technology), anti-FAK (Cell Signaling Technology), anti-Akt (Cell Signaling Technology), anti-p-Akt (Cell Signaling Technology), and anti-β-catenin (ProteinTech Group). After incubation with secondary antibodies (Epizime, China) for 2 h at room

Open access
Shikai Gui Department of Neurosurgery, the 2nd affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China
Nanchang University, Nanchang, Jiangxi Province, China
Institute of Neuroscience, Nanchang University, Nanchang, Jiangxi Province, China

Search for other papers by Shikai Gui in
Google Scholar
PubMed
Close
,
Wanli Yu Department of Neurosurgery, the 2nd affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China
Nanchang University, Nanchang, Jiangxi Province, China
Institute of Neuroscience, Nanchang University, Nanchang, Jiangxi Province, China

Search for other papers by Wanli Yu in
Google Scholar
PubMed
Close
,
Jiabao Xie Department of Neurosurgery, the 2nd affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China
Nanchang University, Nanchang, Jiangxi Province, China
Institute of Neuroscience, Nanchang University, Nanchang, Jiangxi Province, China

Search for other papers by Jiabao Xie in
Google Scholar
PubMed
Close
,
Lunshan Peng Department of Neurosurgery, the 2nd affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China
Nanchang University, Nanchang, Jiangxi Province, China
Institute of Neuroscience, Nanchang University, Nanchang, Jiangxi Province, China

Search for other papers by Lunshan Peng in
Google Scholar
PubMed
Close
,
Yuanyuan Xiong Department of Neurosurgery, the 2nd affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China
Nanchang University, Nanchang, Jiangxi Province, China

Search for other papers by Yuanyuan Xiong in
Google Scholar
PubMed
Close
,
Zhen Song Nanchang University, Nanchang, Jiangxi Province, China
Department of Urology, the 2nd affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China

Search for other papers by Zhen Song in
Google Scholar
PubMed
Close
,
Haitao Luo Department of Neurosurgery, the 2nd affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China

Search for other papers by Haitao Luo in
Google Scholar
PubMed
Close
,
Juexian Xiao Department of Neurosurgery, the 2nd affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China

Search for other papers by Juexian Xiao in
Google Scholar
PubMed
Close
,
Shengtao Yuan Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, Jiangsu Province, China

Search for other papers by Shengtao Yuan in
Google Scholar
PubMed
Close
, and
Zujue Cheng Department of Neurosurgery, the 2nd affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China
Nanchang University, Nanchang, Jiangxi Province, China
Institute of Neuroscience, Nanchang University, Nanchang, Jiangxi Province, China

Search for other papers by Zujue Cheng in
Google Scholar
PubMed
Close

found that SLC7A11 functions as an invasive biomarker and was highly expressed in invasive PitNETs. In addition, knockdown of SLC7A11 inhibited epithelial–mesenchymal transition (EMT) through the PI3K/AKT signaling pathway. Materials and methods

Open access
Hanrong Zhang H Zhang, Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Search for other papers by Hanrong Zhang in
Google Scholar
PubMed
Close
,
Junxin Chen J Chen, Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Search for other papers by Junxin Chen in
Google Scholar
PubMed
Close
,
Xin Chen X Chen, Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Search for other papers by Xin Chen in
Google Scholar
PubMed
Close
,
Chuimian Zeng C Zeng, Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Search for other papers by Chuimian Zeng in
Google Scholar
PubMed
Close
,
Pengyuan Zhang P Zhang, Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Search for other papers by Pengyuan Zhang in
Google Scholar
PubMed
Close
,
Jiewen Jin J Jin, Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Search for other papers by Jiewen Jin in
Google Scholar
PubMed
Close
,
Haipeng Xiao H Xiao, Endocrinology, The first affiliated hospital of Sun Yat-sen University, Guangzhou, China

Search for other papers by Haipeng Xiao in
Google Scholar
PubMed
Close
,
Yanbing Li Y Li, Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guanzhou, China

Search for other papers by Yanbing Li in
Google Scholar
PubMed
Close
,
Hongyu Guan H Guan, Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Search for other papers by Hongyu Guan in
Google Scholar
PubMed
Close
, and
Hai Li H Li, Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Search for other papers by Hai Li in
Google Scholar
PubMed
Close

Background: Transforming growth factor beta receptor III (TGFBR3) has been shown to play a tumor suppressive role in a variety of cancers. However, its role in papillary thyroid cancer (PTC) remains unknown.

Method: TGFBR3 expression levels in PTC were analyzed utilizing TCGA and GEO database. Edu, wounding healing and Transwell assays were used to evaluate cell proliferation, migration and invasion. Transcriptome sequencing, qRT-PCR and Western blotting were used to detect the underlying mechanism of TGFBR3 in PTC progression.

Result: This study demonstrated that TGFBR3 expression was significantly down-regulated in PTC compared to normal thyroid tissues. Low expression of TGFBR3 was associated with poor prognosis of patients with PTC. Furthermore, TGFBR3 expression positively correlated with thyroid differentiation score. In investigating the biological impact of TGFBR3 over-expression in PTC cell lines, we found that the proliferation, migration and invasion of PTC cells were significantly inhibited in response to TGFBR3 overexpression. Moreover, we also demonstrated that overexpression of TGFBR3 inhibited PI3K/AKT pathway and epithelial mesenchymal transformation processes. Lastly, TGFBR3 expression was found to be involved in tumor immune infiltration, highlighting its potential influence on immune dynamics within the tumor microenvironment in PTC.

Conclusion: TGFBR3 plays a tumor suppressive role in PTC progression by inhibiting PI3K/AKT pathway and EMT.

Open access
Myrian Velasco Neuroscience Division, Department of Cognitive Neuroscience, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico

Search for other papers by Myrian Velasco in
Google Scholar
PubMed
Close
,
Rosa Isela Ortiz-Huidobro Neuroscience Division, Department of Cognitive Neuroscience, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico

Search for other papers by Rosa Isela Ortiz-Huidobro in
Google Scholar
PubMed
Close
,
Carlos Larqué Department of Embryology and Genetics, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico

Search for other papers by Carlos Larqué in
Google Scholar
PubMed
Close
,
Yuriko Itzel Sánchez-Zamora Neuroscience Division, Department of Cognitive Neuroscience, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico

Search for other papers by Yuriko Itzel Sánchez-Zamora in
Google Scholar
PubMed
Close
,
José Romo-Yáñez Department of Gynecological and Perinatal Endocrinology, Instituto Nacional de Perinatología ‘Isidro Espinosa de los Reyes’, Mexico City, Mexico

Search for other papers by José Romo-Yáñez in
Google Scholar
PubMed
Close
, and
Marcia Hiriart Neuroscience Division, Department of Cognitive Neuroscience, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico

Search for other papers by Marcia Hiriart in
Google Scholar
PubMed
Close

insulin binding, its receptor is auto-phosphorylated and activates several downstream targets such as IRS1 and kinases such as PI3K, and AKT, which are critical nodes in the insulin signaling pathway ( 18 ). PI3K/AKT pathway regulates glucose uptake

Open access
Shenghe Luo College of Pharmacy, Yanbian University, Yanji, China

Search for other papers by Shenghe Luo in
Google Scholar
PubMed
Close
,
Yunhui Zuo Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji, China
Department of Cardiology, Yanbian University Hospital, Yanji, China

Search for other papers by Yunhui Zuo in
Google Scholar
PubMed
Close
,
Xiaotian Cui Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji, China

Search for other papers by Xiaotian Cui in
Google Scholar
PubMed
Close
,
Meiping Zhang Department of Cardiology, Yanbian University Hospital, Yanji, China

Search for other papers by Meiping Zhang in
Google Scholar
PubMed
Close
,
Honghua Jin Department of Pharmacy, Yanbian University Hospital, Yanji, China

Search for other papers by Honghua Jin in
Google Scholar
PubMed
Close
, and
Lan Hong Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji, China

Search for other papers by Lan Hong in
Google Scholar
PubMed
Close

), the bands were processed with Image J software (National Institutes of Health, Bethesda, MD, USA). The following antibodies were used in this experiment: Anti-GLP1-1R Antibody (ab218532, Abcam), AKT (phospho-S473) polyclonal antibody(80455

Open access
Flavia Letícia Martins Peçanha Instituto de Bioquímica Médica Leopoldo de Meis, Laboratório de Adaptações Metabólicas, Programa de Bioquímica e Biofísica Celular, Universidade Federal do Rio de Janeiro, Cidade Universitária, Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Flavia Letícia Martins Peçanha in
Google Scholar
PubMed
Close
,
Reinaldo Sousa dos Santos Instituto de Bioquímica Médica Leopoldo de Meis, Laboratório de Adaptações Metabólicas, Programa de Bioquímica e Biofísica Celular, Universidade Federal do Rio de Janeiro, Cidade Universitária, Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Reinaldo Sousa dos Santos in
Google Scholar
PubMed
Close
, and
Wagner Seixas da-Silva Instituto de Bioquímica Médica Leopoldo de Meis, Laboratório de Adaptações Metabólicas, Programa de Bioquímica e Biofísica Celular, Universidade Federal do Rio de Janeiro, Cidade Universitária, Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Wagner Seixas da-Silva in
Google Scholar
PubMed
Close

. Gottlob ( 28 ) and Majewski ( 29 ) found that AKT, also known as protein kinase B, increases the basal levels of HK units bound to mitochondria. A few years later, it was demonstrated that this interaction was a consequence of direct phosphorylation of HK

Open access
Simon Schimmack European Pancreas Center, Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany

Search for other papers by Simon Schimmack in
Google Scholar
PubMed
Close
,
Yongchao Yang European Pancreas Center, Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany
Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China
Department of Burns and Plastic Surgery, The Third Xiangya Hospital, Central South University, Changsha, China

Search for other papers by Yongchao Yang in
Google Scholar
PubMed
Close
,
Klaus Felix European Pancreas Center, Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany

Search for other papers by Klaus Felix in
Google Scholar
PubMed
Close
,
Markus Herbst European Pancreas Center, Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany

Search for other papers by Markus Herbst in
Google Scholar
PubMed
Close
,
Yixiong Li Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China

Search for other papers by Yixiong Li in
Google Scholar
PubMed
Close
,
Miriam Schenk European Pancreas Center, Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany

Search for other papers by Miriam Schenk in
Google Scholar
PubMed
Close
,
Frank Bergmann Institute of Pathology, Heidelberg University, Heidelberg, Germany

Search for other papers by Frank Bergmann in
Google Scholar
PubMed
Close
,
Thilo Hackert European Pancreas Center, Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany

Search for other papers by Thilo Hackert in
Google Scholar
PubMed
Close
, and
Oliver Strobel European Pancreas Center, Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany

Search for other papers by Oliver Strobel in
Google Scholar
PubMed
Close

), anti-total-ERK, anti-phospho-ERK (Thr202/Tyr204), anti-total-AKT and anti-phosho-AKT (Ser473) (all Cell Signaling). The secondary antibody used was goat anti-rabbit (R&D Systems). Quantification of protein expression was performed using ImageJ (EHD

Open access